S&P 500   4,584.84 (+0.73%)
DOW   35,646.40 (+0.44%)
QQQ   383.09 (+0.81%)
AAPL   152.33 (+2.34%)
MSFT   323.02 (-0.05%)
FB   315.00 (+0.89%)
GOOGL   2,921.77 (-0.09%)
TSLA   1,073.39 (+3.42%)
AMZN   3,469.22 (+2.26%)
NVDA   247.15 (+1.08%)
BABA   169.94 (+0.42%)
NIO   40.27 (+2.44%)
CGC   12.87 (+0.70%)
GE   104.09 (+0.23%)
AMD   120.95 (-1.09%)
MU   69.41 (+1.71%)
T   25.56 (+2.00%)
F   16.82 (+8.45%)
ACB   6.85 (+0.15%)
DIS   170.10 (+0.32%)
PFE   43.13 (+0.37%)
BA   206.78 (+0.08%)
AMC   34.94 (+0.52%)
S&P 500   4,584.84 (+0.73%)
DOW   35,646.40 (+0.44%)
QQQ   383.09 (+0.81%)
AAPL   152.33 (+2.34%)
MSFT   323.02 (-0.05%)
FB   315.00 (+0.89%)
GOOGL   2,921.77 (-0.09%)
TSLA   1,073.39 (+3.42%)
AMZN   3,469.22 (+2.26%)
NVDA   247.15 (+1.08%)
BABA   169.94 (+0.42%)
NIO   40.27 (+2.44%)
CGC   12.87 (+0.70%)
GE   104.09 (+0.23%)
AMD   120.95 (-1.09%)
MU   69.41 (+1.71%)
T   25.56 (+2.00%)
F   16.82 (+8.45%)
ACB   6.85 (+0.15%)
DIS   170.10 (+0.32%)
PFE   43.13 (+0.37%)
BA   206.78 (+0.08%)
AMC   34.94 (+0.52%)
S&P 500   4,584.84 (+0.73%)
DOW   35,646.40 (+0.44%)
QQQ   383.09 (+0.81%)
AAPL   152.33 (+2.34%)
MSFT   323.02 (-0.05%)
FB   315.00 (+0.89%)
GOOGL   2,921.77 (-0.09%)
TSLA   1,073.39 (+3.42%)
AMZN   3,469.22 (+2.26%)
NVDA   247.15 (+1.08%)
BABA   169.94 (+0.42%)
NIO   40.27 (+2.44%)
CGC   12.87 (+0.70%)
GE   104.09 (+0.23%)
AMD   120.95 (-1.09%)
MU   69.41 (+1.71%)
T   25.56 (+2.00%)
F   16.82 (+8.45%)
ACB   6.85 (+0.15%)
DIS   170.10 (+0.32%)
PFE   43.13 (+0.37%)
BA   206.78 (+0.08%)
AMC   34.94 (+0.52%)
S&P 500   4,584.84 (+0.73%)
DOW   35,646.40 (+0.44%)
QQQ   383.09 (+0.81%)
AAPL   152.33 (+2.34%)
MSFT   323.02 (-0.05%)
FB   315.00 (+0.89%)
GOOGL   2,921.77 (-0.09%)
TSLA   1,073.39 (+3.42%)
AMZN   3,469.22 (+2.26%)
NVDA   247.15 (+1.08%)
BABA   169.94 (+0.42%)
NIO   40.27 (+2.44%)
CGC   12.87 (+0.70%)
GE   104.09 (+0.23%)
AMD   120.95 (-1.09%)
MU   69.41 (+1.71%)
T   25.56 (+2.00%)
F   16.82 (+8.45%)
ACB   6.85 (+0.15%)
DIS   170.10 (+0.32%)
PFE   43.13 (+0.37%)
BA   206.78 (+0.08%)
AMC   34.94 (+0.52%)

The Latest: Russia sets another daily virus death record

Wednesday, October 13, 2021 | The Associated Press


A medical worker helps a patient suspected of having coronavirus to leave an ambulance at a hospital in Kommunarka, outside Moscow, Russia, Tuesday, Oct. 12, 2021. Russia hit another record of daily coronavirus deaths Tuesday as the country struggled with a rapid surge of infections and lagging vaccination rates, but authorities have been adamant that there would be no new national lockdown. (AP Photo/Alexander Zemlianichenko)

MOSCOW — Russia has reported a record 984 daily coronavirus deaths amid a slow vaccination rate.

It’s marked several record daily death tolls in the past few weeks. Infections have soared to near all-time highs, with 28,717 confirmed cases reported Wednesday.

The Kremlin has attributed the mounting contagion and deaths to slow vaccinations. Prime Minister Mikhail Mishustin said Tuesday about 29% of the country’s nearly 146 million people were fully vaccinated.

President Vladimir Putin emphasized the need to speed up the vaccination rate on Tuesday, but he also has cautioned against forcing people to get the shots. Health experts have attributed the slow pace of vaccination to widespread vaccine skepticism and disinformation.

The Kremlin has ruled out a new nationwide lockdown similar to the one during the first months of the pandemic that badly crippled the economy and dented Putin’s ratings. It has delegated the power to enforce coronavirus restrictions to regional authorities.

The increased infections have increased the pressure on Russia’s health care system. Speaking at a Cabinet meeting Tuesday, Health Minister Mikhail Murashko said 11% of Russia’s 235,000 hospitalized COVID-19 patients are in serious or critical condition.

Russia’s coronavirus task force has confirmed more than 7.8 million cases and 219,329 deaths -- the highest death toll in Europe. Russia trails the U.S (718,000), Brazil (601,000) India (451,000) and Mexico (283,000) in confirmed global deaths.

___

MORE ON THE PANDEMIC:

— US to reopen land borders in November to fully vaccinated vacation travelers

— Conservative state Republicans move to undercut private employer vaccine mandates

— Russia hits new record for COVID-19 deaths, resists lockdown

___

See all of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic

___

HERE’S WHAT ELSE IS HAPPENING:

BUCHAREST, Romania — Romania received 5,200 doses of monoclonal antibodies from Italy to assist with a rapid surge of infections amid low vaccination rates.

Coronavirus infections in Romania, a European Union nation of 19 million, have skyrocketed in the last month from around 2,000 daily cases to pandemic highs of nearly 17,000 this week. It registered 442 deaths on Tuesday, the highest toll since the start of the pandemic.

The antibodies, which are used to treat COVID-19 patients in the early stages of a coronavirus infection, were brought to Bucharest from Milan by the Romanian Air Force on Tuesday evening, Romania’s defense ministry said in a statement.

The ministry says the aid is part of a request Romania made last week to the EU for help through its EU Civil Protection Mechanism.

Romania has fully vaccinated only 34% of adults, the second-least vaccinated country in the EU behind Bulgaria. Romania has confirmed more than 1.3 million cases and 40,461 deaths.

___

WASHINGTON — The U.S. will reopen its land borders to nonessential travel next month, ending a 19-month freeze due to the COVID-19 pandemic.

The new rules, announced Wednesday, will allow fully vaccinated foreign nationals to enter the U.S. regardless of the reason for travel starting in early November, when a similar easing of restrictions is set to kick in for air travel into the country. By mid-January, essential travelers seeking to enter the U.S., such as truck drivers, will need to be fully vaccinated.

Vehicle, rail and ferry travel between the U.S. and Canada and Mexico has been largely restricted to essential travel, such as trade, since the earliest days of the pandemic.

Homeland Security Secretary Alejandro Mayorkas said he was “pleased to be taking steps to resume regular travel in a safe and sustainable manner."

Unlike air travel, for which proof of a negative COVID-19 test is required before boarding a flight to enter the U.S., no testing will be required to enter the U.S. by land or sea, provided the travelers meet the vaccination requirement.

___

SEKE, Zimbabwe — The Apostolic church is one of Zimbabwe’s most skeptical groups when it comes to COVID-19 vaccines. It is also one of the southern African nation’s largest religious denominations.

But many of these Christian churches, which combine traditional beliefs with a Pentecostal doctrine, preach against modern medicine and demand followers seek healing or protection against disease through spiritual means like prayer and the use of holy water.

Some secluded Apostolic groups believe vaccines are linked to Satanism. To combat that, authorities have formed teams of campaigners who are also churchgoers to dispel misconceptions about the vaccines in their own churches.

While slow and steady might be best in dealing with some religious hesitancy, the situation is urgent in Africa, which has the world’s lowest vaccination rates. Zimbabwe has fully vaccinated 15% of its population, much better than many other African nations but still far behind the United States and Europe.

___

JUNEAU, Alaska — Two Alaska state senators have tested positive for the coronavirus and a third was not feeling well and awaiting test results, according to Senate President Peter Micciche.

He didn't identify the lawmakers who had tested positive.

Lawmakers are in the second week of their fourth special session of the year. Six of the Senate’s 20 members attended Tuesday’s floor session, which was a so-called technical session where no formal business was taken up.

Micciche said some senators had put off trips and were unable to be in Juneau Tuesday, prompting the technical session.

Masks are required at legislative facilities, including the Capitol, though individual lawmakers can decide if they want to wear masks in their respective offices. Legislators and legislative staff also participate in regular testing under a recently adopted policy.

___

SALT LAKE CITY — With the governor of Texas leading the charge, conservative Republicans in several states are moving to block or undercut U.S. President Joe Biden’s COVID-19 vaccine mandates for private employers before the regulations are even issued.

The growing battle over what some see as overreach by the federal government is firing up a segment of the Republican Party base, even though many large employers have already decided on their own to require their workers to get the shot.

The dustup will almost certainly end up in court since GOP attorneys general in nearly half of the states have vowed to sue once the rule requiring workers at private companies with more than 100 employees to get vaccinated or tested weekly is unveiled.

The courts have long upheld vaccine mandates, and the Constitution gives the federal government the upper hand over the states. However, with the details still unannounced and more conservative judges on the bench, the outcome isn’t entirely clear.

On Monday, Texas Gov. Greg Abbott issued an executive order barring private companies or any other entity from requiring vaccines. States weighing or advancing bills include Arkansas and Ohio, and there are calls for special sessions in Wyoming, Kansas, South Dakota, Indiana and Tennessee.

___

WASHINGTON — The Biden’s administration’s mandate that employers with 100 or more workers require coronavirus vaccinations or institute weekly virus testing has moved one step closer to enforcement.

On Tuesday, the Occupational Safety and Health Administration finalized the initial draft of the emergency order and sent it to the White House Office of Management and Budget for review. That’s according to the Department of Labor.

OMB’s Office of Information and Regulatory Affairs will conduct a standard review of the regulation.

Officials didn't immediately provide an estimate for the OMB examination. The agency has 90 days to review the rule or send it back to OSHA for revision. Text of the proposed order won’t be published until OMB completes its review.

Owing to the bureaucracy surrounding the rulemaking process, President Joe Biden has encouraged businesses to implement mandates ahead of the final rule being implemented.

___

SAN JUAN, Puerto Rico — Puerto Rico’s governor says he'll lift a curfew and a ban on alcohol sales as the U.S. territory reports a drop in the number of COVID-19 hospitalizations and deaths.

Current restrictions prohibit certain businesses from operating between midnight and 5 a.m. and also bar alcohol sales during that time, two measures that will be lifted Thursday. Gov. Pedro Pierluisi says other restrictions, including an indoors mask requirement, remain in place.

He says 70% of the island’s 3.3 million people are vaccinated, and the positivity rate for coronavirus tests dropped to 3%, compared with 10% in August.

Puerto Rico has confirmed more than 150,500 cases and more than 3,000 deaths from the coronavirus.

___

LEWISTON, Maine — Staffing shortages at one of Maine’s biggest hospitals have forced it to halt pediatric and trauma admissions, renewing a debate over the governor’s vaccine mandate for health care workers.

Citing “acute staffing shortages,” Central Maine Medical Center temporarily suspended but later reinstated heart attack admissions and will be reviewing trauma admissions on an ongoing basis, the hospital said in a statement Tuesday.

The neonatal intensive care unit is closing and the suspension of pediatric admissions will continue until further notice, the hospital said.

Earlier this month, the hospital’s chief medical officer said about 70 employees left due to the COVID-19 vaccine requirement. The deadline was Oct. 1 but state officials said they won't start enforcing it until Oct. 29.

Republican leaders in the Maine Legislature sent a letter to Democratic leaders urging lawmakers to return to session to include a testing option for health care workers who don’t want the vaccine.

___

SEATTLE — Boeing Co. has told employees they must be vaccinated against the coronavirus or possibly be fired.

The Seattle Times reports that the deadline for getting shots is Dec. 8.

The newspaper says an internal Boeing presentations says that employees failing to comply with the mandate “may be released from the company.” Employees granted exemptions “due to a disability or sincerely held religious belief” will have to be tested frequently for the virus and be ready to “present a negative test result upon request.”

The policy will apply to roughly 140,000 employees companywide, with about 57,000 of those in Washington state.

The white-collar union the Society of Professional Engineering Employees in Aerospace says it is communicating with Boeing “to ensure implementation gives proper consideration to members’ concerns.”

___

NEW YORK — NBA star Kyrie Irving can keep refusing to get the COVID-19 vaccine, but he can’t play for the Brooklyn Nets.

The Nets announced Irving wouldn’t play or practice with the team until he could be a full participant, ending the idea he could play only road games. Under a New York City mandate, professional athletes playing for a team in the city must be vaccinated against COVID-19 to play or practice in public venues.

Without mentioning his vaccination status, general manager Sean Marks said Irving has made a decision that keeps him from being a full member of the team. Irving hasn’t said he isn’t vaccinated, asking for privacy when he spoke via Zoom during the team’s media day on Sept. 27.

Marks said he and owner Joe Tsai made the decision, adding it came through discussions with Irving and his associates. NBA players are not required to be vaccinated, but they face more testing and social distancing. The league had said that players wouldn’t be paid for games they miss because they are ineligible to play.

Marks said Irving will still be paid for road games.

___

NEW YORK — Many Americans who got Pfizer vaccinations are rolling up their sleeves for a booster shot. Meanwhile, millions who received the Moderna or Johnson & Johnson vaccine wait to learn when it’s their turn.

Federal regulators begin tackling that question this week. On Thursday and Friday, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra shots of the two vaccines should be dispensed and, if so, who should get them and when.

The final go-ahead is not expected for at least another week. After the FDA advisers give their recommendation, the agency will make an official decision on whether to authorize boosters. Then a panel convened by the Centers for Disease Control and Prevention will offer more specifics on who should get them.

The FDA meetings come as U.S. vaccinations have climbed back above 1 million per day on average, an increase of more than 50% over the past two weeks. The rise has been driven mainly by Pfizer boosters and employer vaccine mandates.

___

Should you invest $1,000 in The Boeing right now?

Before you consider The Boeing, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Boeing wasn't on the list.

While The Boeing currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)2.8$162.94-0.5%2.60%24.50Buy$189.75
The Boeing (BA)2.1$206.78+0.1%N/A-13.46Buy$268.80
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.